Ever been stuck on the road far from home with a breakdown? Not fun. So imagine getting an email or text warning weeks or months before a starter quits, a battery dies or a fuel pump fails. Some of ...

The average one-year price target for Sera Prognostics (NasdaqGM:SERA) has been revised to $5.10 / share. This is an increase ...

The Company also hosted a virtual R&D day in conjunction with the SMFM Pregnancy Meeting further showcasing results of the PRIME study. During these events, Dr. Iriye shared a presentation ...

DALLAS. Prognostics – being able to predict a component or part failure in advance – will be the true growth area in telematics in the coming decade, at least in North America and Europe, a leading ...

"Lee is a highly accomplished leader with commercial expertise in fostering innovation, supporting continuous optimization and driving sales and offers a history of strong performance within the ...

Alerted by prognostics to a problem with a component or part, a fleet may not choose to take a risk on it performing another 20,000 miles before regularly scheduled truck maintenance. “Because it’s 50 ...

The company reiterated plans to publish the PRIME study in a peer-reviewed journal by year-end and to host an investor and analyst event immediately following acceptance. Management expects a "steady ...

Sera Prognostics is a promising company with a mission to improve pregnancy outcomes through its blood test product, PreTRM, which identifies biomarkers linked to premature birth. Premature birth is a ...

SERA is trading near the bottom of its 52-week range and near its 200-day simple moving average. Price change The price of SERA shares has decreased $0.37 since the market last closed. This is a 11.31 ...

Sera Prognostics, which develops diagnostic tests for pregnancy complications, raised $75 million by offering 4.7 million shares at $16, within the range of $15 to $17. Sera Prognostics uses its ...

Sera Prognostics reported its Q3 2025 earnings, revealing a mixed financial performance. The company posted an earnings per share (EPS) of -$0.16, outperforming the forecasted -$0.23, marking a 30.43% ...

Established in 2018, the company leverages deep learning and machine learning algorithms to generate brain scan analyses to aid the assessment and early detection of neurological disorders, including ...